Jinhua®Transfer Factor Capsules

Brand Name‌: Jinhua
Generic Name‌: Transfer Factor Capsules
R&D and Manufacturing Enterprise‌: Jinhua Enterprise (Group) Co., Ltd. Xi’an Jinhua Pharmaceutical Factory
Approval & Launch Time‌: Approved for marketing with the NMPA approval number H20013360, officially launched in 2001
Storage Requirements‌: Sealed, stored in a cool and dark place, protected from high temperature and moisture
Specification‌: 3mg (polypeptide) : 100μg (ribose) per capsule, the common commercial package is 24 capsules per box

Category:

Description‌
Jinhua Brand Transfer Factor Capsules is a prescription chemical drug with the NMPA approval number ‌Guoyao Zhunzi H20013360‌. Its main active ingredient is small molecular polypeptides and nucleotides extracted from healthy bovine spleen. The content inside the capsule is off-white powder, and it belongs to a bidirectional immune modulator.

Indications‌
It is used for adjuvant treatment of viral or mycotic intracellular infections that are difficult to control with certain antibiotics, such as herpes zoster, Candida albicans infection, viral myocarditis, etc. It can also be used as an adjuvant therapeutic agent for malignant tumors, and has certain curative effect on immune deficiency diseases such as eczema, thrombocytopenia, and repeated infection syndrome.

Dosage and Administration‌

Administration‌: Oral administration, swallow the capsules whole with warm water, do not chew or break the contents.
Dosage‌: 3 capsules each time, 3 times a day. The specific dosage can be adjusted according to the doctor’s advice.

Precautions‌
Do not take it together with hot drinks or hot food, to avoid high temperature destroying the active ingredients of the drug and reducing the curative effect. If the content of the capsule becomes turbid or discolored, stop using it immediately.

Contraindications‌
People who are allergic to any component of this product are strictly prohibited from using it.

Adverse Reactions‌
No clear related adverse reactions have been reported in clinical application so far, and no serious adverse events related to the drug have been recorded.

Drug Interactions‌
At present, no clinically significant adverse drug interactions have been confirmed. If you are taking other drugs at the same time, please consult a doctor or pharmacist before use.

Special Populations‌
Children, elderly patients: There is a lack of complete and reliable clinical research data, and they must use it under the guidance of a physician.
Pregnant and lactating women: The safety of medication has not been clearly verified, and it is not recommended to use it without professional medical advice.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.